Structurally well-defined macrophage activating factor derived from vitamin D3-binding protein has a potent adjuvant...

Area of Science:

• Immunology
• Biochemistry

Background:

• Freund's adjuvant induces inflammation, augmenting antibody development.
• Macrophage activation is crucial for antibody development, making inflammation-primed macrophages key to immune responses.
• Macrophage activating factors are potential adjuvants for immunization.

Purpose of the Study:

• To investigate the potential of macrophage activating factors as adjuvants.
• To generate and characterize a novel macrophage activating factor (GcMAF).
• To evaluate the adjuvant activity of GcMAF in immunization and anti-tumor responses.

Main Methods:

• Generation of GcMAF through stepwise incubation of Gc protein with beta-galactosidase and sialidase.
• Administration of GcMAF to mice to assess macrophage activation and progenitor cell stimulation.
• Evaluation of GcMAF's adjuvant effect by co-administering it with antigens (SRBC, tumor cells) and assessing antibody production and tumor transplantability.

Main Results:

• GcMAF administration stimulated progenitor cells and activated macrophages.
• GcMAF demonstrated potent adjuvant activity, significantly increasing anti-SRBC antibody-secreting cells post-immunization.
• GcMAF-primed immunization rendered mice resistant to transplantable Ehrlich ascites tumor cells.

Conclusions:

• GcMAF is a potent macrophage activating factor with significant adjuvant properties.
• GcMAF enhances antibody production and immune responses, showing potential in immunotherapy and vaccine development.
• GcMAF exhibits anti-tumor activity, suggesting its utility against poorly immunogenic cancers.